Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio.
Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories.
Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life.
In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Every day, more than 500,000 customers around the world rely on QIAGEN solutions to extract meaning from genetic material quickly, confidently and accurately. Whether the goal is driving discovery, diagnosing disease or guiding treatment decisions, QIAGEN technologies help make the process reliable, fast and more impactful.
These customers include young scientists, pharma R&D teams, clinical labs and more than 35 Nobel Prize winners, all choosing QIAGEN to help advance science and improve outcomes. QIAGEN is not just a supplier of kits and instruments. We are a partner in progress, backed by a deep commitment to science and better healthcare.
In a world where the stakes continue to rise and the questions grow more complex, QIAGEN exists to accelerate the breakthroughs science and society urgently need, by advancing science and improving healthcare. This is how we make improvements in life possible. Discover more at ➡️ http://www.qiagen.com